Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,429 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Head-to-head comparisons of [68Ga]Ga-PSMA-11 PET/CT, multiparametric MRI, and prostate-specific antigen for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer patients: a prospective study.
Ke ZB, Chen SM, Chen JY, Chen SH, You Q, Sun JB, Xue YT, Sun XL, Wu XH, Zheng QS, Wei Y, Xue XY, Xu N. Ke ZB, et al. Among authors: chen jy, chen sh, chen sm. Eur J Nucl Med Mol Imaging. 2023 Mar;50(4):1240-1251. doi: 10.1007/s00259-022-06047-6. Epub 2022 Nov 22. Eur J Nucl Med Mol Imaging. 2023. PMID: 36416906
Role of 18F-FDG-PET/CT in Combination With Neutrophil-Lymphocyte Ratio in the Diagnosis of Upper Urinary Tract Lesion: Can We Accurately Predict Malignant Tumor?
Ke ZB, Lin XD, Chen YH, Lin YZ, Chen SH, Chen SM, Chen Y, Wei Y, Zheng QS, Xue XY, Li XD, Xu N. Ke ZB, et al. Among authors: chen yh, chen sh, chen sm, chen y. Front Oncol. 2021 Sep 22;11:615881. doi: 10.3389/fonc.2021.615881. eCollection 2021. Front Oncol. 2021. PMID: 34631509 Free PMC article.
Low TLR and PSMA-TV predict biochemical response to abiraterone acetate in metastatic prostate cancer patients developing castration resistance after chemohormonal therapy at hormone-sensitive stage.
Ke ZB, Chen JY, You Q, Sun JB, Xue YT, Ye XJ, Chen SH, Xue XY, Sun XL, Chen DN, Wei Y, Zheng QS, Chen SM, Xu N. Ke ZB, et al. Among authors: chen jy, chen sh, chen dn, chen sm. J Cancer Res Clin Oncol. 2023 Jul;149(8):5071-5084. doi: 10.1007/s00432-022-04438-8. Epub 2022 Nov 4. J Cancer Res Clin Oncol. 2023. PMID: 36333565
1,429 results